SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-033906
Filing Date
2022-02-10
Accepted
2022-02-10 11:10:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d311297dsc13g.htm SC 13G 33106
  Complete submission text file 0001193125-22-033906.txt   34784
Mailing Address 60 ROUTE DE ACACIAS GENEVA 73 V8 1211
Business Address 60 ROUTE DE ACACIAS GENEVA 73 V8 1211 011 44 207 847 5040
PICTET ASSET MANAGEMENT SA (Filed by) CIK: 0001361570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88050 | Film No.: 22612075
SIC: 2834 Pharmaceutical Preparations